Regenerex Pharma (RGPX) Shares Outstanding (Weighted Average) (2010 - 2025)

Regenerex Pharma (RGPX) has 14 years of Shares Outstanding (Weighted Average) data on file, last reported at $281.4 million in Q3 2025.

• Quarterly Shares Outstanding (Weighted Average) rose 9569.65% year-over-year to $281.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $281.4 million (up 9569.65% YoY) and the FY2025 annual result came in at $278.7 million, changed 0.39% from the prior year.
• Shares Outstanding (Weighted Average) steadied at $281.4 million in Q3 2025 per RGPX's latest filing, from $281.1 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $281.4 million in Q3 2025 and bottomed at $1.1 million in Q2 2023.
• The 5-year median for Shares Outstanding (Weighted Average) is $155.3 million (2021), against an average of $153.4 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) tumbled 99.12%; it then surged 10181.55% in 2025.
• Tracing RGPX's Shares Outstanding (Weighted Average) over 5 years: stood at $203.7 million in 2021, then slumped by 37.61% to $127.1 million in 2022, then surged by 118.34% to $277.5 million in 2023, then sank by 98.91% to $3.0 million in 2024, then surged by 9168.37% to $281.4 million in 2025.
• Per Business Quant, the three latest RGPX Shares Outstanding (Weighted Average) figures stand at $281.4 million (Q3 2025), $281.1 million (Q2 2025), and $278.7 million (Q1 2025).

Peer Comparison